India, July 22 -- image credit- shutterstock

US President Donald J Trump has stated that effective August 1st, 2026, all generic drugs being brought into the United States (US) will continue to have a tariff of zero percent for a two year period of time, after which the tariff will be raised to 100% for a one year period of time, and 200% thereafter.

This is apparently being done in order to reshore Generic Pharmaceutical Production into America, with a penalty to those companies that decide not to build plant and equipment within the stated period of time given to them.

According to Trump, the objective of this Policy is to protect the people of the United States. The Policy on Patented, Branded, or Innovative Drugs, which has been so...